483
Sharplight TechnologiesSharplight Technologies – FDA 483, Feb 14, 2019
Record Details
An FDA inspection of SharpLight Technologies, a medical device firm in Rishon le-Tsiyon, Israel, revealed significant quality system deficiencies. The firm failed to adequately establish corrective and preventive action procedures and did not properly document design review results. Additionally, SharpLight Technologies introduced several class 2 medical/class IV laser devices into U.S. commerce without submitting required product reports and annual reports to the FDA.
View Company Profile
ID · 8fe6f9fc-6edb-4169-a07f-c95703f02ef7
Other documents for Sharplight Technologies
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.